Experience

Rallybio

• United States
• Biotechnology Research
• 1 - 100 Employee

• Program Leadership

  • May 2020 - 3 years 8 months

  Focused on supporting Rallybio’s mission to identify and accelerate the development of transformative and breakthrough therapies for patients with severe and rare disorders



Alexion Pharmaceuticals, Inc.

• United States
• Biotechnology Research
• 700 & Above Employee

• VP, Global Medicine Team Leader

  • Nov 2013 - May 2020

  Connecticut Strategic direction and leadership of global development programs, achieving targeted registrations, label enhancements, post-marketing commitments and registry activities in rare/ultra-rare diseases.



Pfizer

• Events Services
• 1 - 100 Employee

• VP, Late-stage Development Portfolio Operations Management

  • 2011 - Oct 2013

  New London/Norwich, Connecticut Area

• VP, Early Clinical Operations

  • 2009 - 2011

  Leadership of a large, global clinical trial operations group that also included 3 internal Phase 1 Clinical Research Units, to assure delivery of the Early Development portfolio: - First-in-Human through Proof-of-Concept studies - Phase 1 Clinical Pharmacology programs



Pfizer Inc.

• United States
• Hospitals and Health Care

• Global Clinical Leadership

  • Jun 1996 - Dec 2008

  Extensive clinical development experience in multiple therapeutic areas, including clinical leadership experiences in: - Late stage candidate development, US/EU regulatory submission and defence - Early stage drug development (FIH to Phase 2/Proof of Concept)